𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast-conserving surgery with resection of the nipple–areola complex for subareolar breast carcinoma

✍ Scribed by C. Tausch; T. Hintringer; F. Kugler; C. Schmidhammer; M. Bauer; M. Aufschnaiter


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
118 KB
Volume
92
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Introduction

Breast-conserving therapy for centrally located tumours has in the past been viewed with reservation, but is now an accepted treatment. There is little published evidence, however, to show that it is safe and cosmetically acceptable.

Methods

In a prospective investigation carried out between 1996 and 2002, 44 women had surgery for 45 breast carcinomas with suspected nipple involvement. The breast was conserved and the nipple–areola complex removed. Secondary mastectomy was performed in three women because the tumour was found to reach the resection margin. Forty-one women underwent further observation. The mean tumour size at the time of operation was 18 (range 4–50) mm. Six women received preoperative chemotherapy.

Results

Histologically, there were seven preinvasive and 35 invasive cancers. No local failure had occurred at a median follow-up of 51 months. Six women developed distant metastasis, of whom five died. The mean score for cosmetic results (evaluated on a scale of 1–5 where a score of 1 was excellent) was 1·5 for patients and 1·7 for physicians.

Conclusion

Breast-conserving therapy is a safe and cosmetically acceptable alternative to mastectomy for subareolar breast cancer.


📜 SIMILAR VOLUMES


Long term follow-up of women with ductal
✍ Kimberly J. Van Zee; Laura Liberman; Billur Samli; Katherine N. Tran; Beryl McCo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## BACKGROUND. Although in recent years there has been a dramatic increase in both the incidence of ductal carcinoma in situ (DCIS) and breast-conserving therapy for patients who have this disease, the optimal treatment for these patients remains controversial. Most data regarding outcomes have co

A randomized trial of long term adjuvant
✍ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w